Amisulpride Augmentation Therapy for Clozapine-resistant Schizophrenic Patients
NCT01105481
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
273
Enrollment
OTHER
Sponsor class
Conditions
Treatment-resistant Schizophrenia
Interventions
DRUG:
Amisulpride add-on
DRUG:
Placebo add-on
Sponsor
National Health Research Institutes, Taiwan